231 related articles for article (PubMed ID: 12722176)
1. Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease.
Tan EK; Tan Y; Chai A; Tan C; Shen H; Lum SY; Fook-Cheong SM; Teoh ML; Yih Y; Wong MC; Zhao Y
Mov Disord; 2003 May; 18(5):593-5. PubMed ID: 12722176
[TBL] [Abstract][Full Text] [Related]
2. Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks".
Rissling I; Geller F; Bandmann O; Stiasny-Kolster K; Körner Y; Meindorfner C; Krüger HP; Oertel WH; Möller JC
Mov Disord; 2004 Nov; 19(11):1279-84. PubMed ID: 15390060
[TBL] [Abstract][Full Text] [Related]
3. Association study between the -141C Ins/Del and TaqI A polymorphisms of the dopamine D2 receptor gene and alcoholism.
Ishiguro H; Arinami T; Saito T; Akazawa S; Enomoto M; Mitushio H; Fujishiro H; Tada K; Akimoto Y; Mifune H; Shioduka S; Hamaguchi H; Toru M; Shibuya H
Alcohol Clin Exp Res; 1998 Jun; 22(4):845-8. PubMed ID: 9660310
[TBL] [Abstract][Full Text] [Related]
4. The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease.
Paus S; Grünewald A; Klein C; Knapp M; Zimprich A; Janetzky B; Möller JC; Klockgether T; Wüllner U
Mov Disord; 2008 Mar; 23(4):599-602. PubMed ID: 18175338
[TBL] [Abstract][Full Text] [Related]
5. The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease.
Oliveri RL; Annesi G; Zappia M; Civitelli D; De Marco EV; Pasqua AA; Annesi F; Spadafora P; Gambardella A; Nicoletti G; Branca D; Caracciolo M; Aguglia U; Quattrone A
Mov Disord; 2000 Jan; 15(1):127-31. PubMed ID: 10634251
[TBL] [Abstract][Full Text] [Related]
6. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population.
Myhre R; Toft M; Kachergus J; Hulihan MM; Aasly JO; Klungland H; Farrer MJ
Acta Neurol Scand; 2008 Nov; 118(5):320-7. PubMed ID: 18485051
[TBL] [Abstract][Full Text] [Related]
7. Linkage and association of DRD2 gene TaqI polymorphism with schizophrenia in an Iranian population.
Behravan J; Hemayatkar M; Toufani H; Abdollahian E
Arch Iran Med; 2008 May; 11(3):252-6. PubMed ID: 18426314
[TBL] [Abstract][Full Text] [Related]
8. No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms.
Nanko S; Ueki A; Hattori M; Dai XY; Sasaki T; Fukuda R; Ikeda K; Kazamatsuri H
Am J Med Genet; 1994 Dec; 54(4):361-4. PubMed ID: 7726209
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the linkage of the Taq1A and Taq1B loci of the dopamine D2 receptor gene with schizophrenia in patients and their siblings.
Golimbet VE; Aksenova MG; Nosikov VV; Orlova VA; Kaleda VG
Neurosci Behav Physiol; 2003 Mar; 33(3):223-5. PubMed ID: 12762588
[TBL] [Abstract][Full Text] [Related]
10. Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence.
Samochowiec J; Kucharska-Mazur J; Grzywacz A; Jabłoński M; Rommelspacher H; Samochowiec A; Sznabowicz M; Horodnicki J; Sagan L; Pełka-Wysiecka J
Neurosci Lett; 2006 Dec; 410(1):1-5. PubMed ID: 17079080
[TBL] [Abstract][Full Text] [Related]
11. [Linkage sib-pair analysis of dopamine receptor D2 gene Taq1A and Taq1B polymorphism and schizophrenia].
Golimbet VE; Aksenova MG; Nosikov VV; Orlova VA; Kaleda VG
Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(4):43-4. PubMed ID: 12001666
[No Abstract] [Full Text] [Related]
12. Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men.
Costa-Mallen P; Costa LG; Checkoway H
Neurosci Lett; 2005 Sep; 385(2):158-62. PubMed ID: 15955630
[TBL] [Abstract][Full Text] [Related]
13. Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease.
Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
Mov Disord; 2006 Dec; 21(12):2157-64. PubMed ID: 17078049
[TBL] [Abstract][Full Text] [Related]
14. Genetics of Lesch's typology of alcoholism.
Samochowiec J; Kucharska-Mazur J; Grzywacz A; Pelka-Wysiecka J; Mak M; Samochowiec A; Bienkowski P
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):423-7. PubMed ID: 17928119
[TBL] [Abstract][Full Text] [Related]
15. [No association of 141C-ins/del polymorphism in the D2 dopamine receptor gene in schizophrenia].
Rohrmeier T; Putzhammer A; Sartor H; Knapp M; Albus M; Borrmann-Hassenbach M; Lichtermann D; Wildenauer D; Schwab S; Maier W; Klein HE; Eichhammer P
Psychiatr Prax; 2003 May; 30 Suppl 2():S212-5. PubMed ID: 14509080
[TBL] [Abstract][Full Text] [Related]
16. Toward identification of susceptibility genes for sporadic Parkinson's disease.
Toda T; Momose Y; Murata M; Tamiya G; Yamamoto M; Hattori N; Inoko H
J Neurol; 2003 Oct; 250 Suppl 3():III40-3. PubMed ID: 14579123
[TBL] [Abstract][Full Text] [Related]
17. Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.
McGuire V; Van Den Eeden SK; Tanner CM; Kamel F; Umbach DM; Marder K; Mayeux R; Ritz B; Ross GW; Petrovitch H; Topol B; Popat RA; Costello S; Manthripragada AD; Southwick A; Myers RM; Nelson LM
J Neurol Sci; 2011 Aug; 307(1-2):22-9. PubMed ID: 21663922
[TBL] [Abstract][Full Text] [Related]
18. Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders.
Vallelunga A; Flaibani R; Formento-Dojot P; Biundo R; Facchini S; Antonini A
Parkinsonism Relat Disord; 2012 May; 18(4):397-9. PubMed ID: 22113132
[TBL] [Abstract][Full Text] [Related]
19. DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls.
Costa-Mallen P; Afsharinejad Z; Kelada SN; Costa LG; Franklin GM; Swanson PD; Longstreth WT; Viernes HM; Farin FM; Smith-Weller T; Checkoway H
Mov Disord; 2004 Jan; 19(1):76-83. PubMed ID: 14743364
[TBL] [Abstract][Full Text] [Related]
20. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.
Kustanovich V; Ishii J; Crawford L; Yang M; McGough JJ; McCracken JT; Smalley SL; Nelson SF
Mol Psychiatry; 2004 Jul; 9(7):711-7. PubMed ID: 14699430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
